Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 6/20 | 0.47 |
| ▸ | ARG1 | P05089 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 5/20 | 0.39 |
| ▸ | MASP2 | O00187 | 3/20 | 0.39 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.35 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23118028 | 0.84 | GRIK1 (0.49) | GRIK1ARG1HRH3F2MASP2 | |
| SCHEMBL11242281 | 0.82 | GRIK1 (0.52) | GRIK1ARG1HRH3F2MASP2 | |
| SCHEMBL11242285 | 0.82 | GRIK1 (0.52) | GRIK1ARG1HRH3F2MASP2 | |
| SCHEMBL199035 | 0.80 | HRH3 (0.54) | GRIK1ARG1HRH3F2MASP2 | |
| SCHEMBL22536533 | 0.80 | HRH3 (0.54) | GRIK1ARG1HRH3F2MASP2 | |
| SCHEMBL3190846 | 0.80 | HRH3 (0.54) | GRIK1ARG1HRH3F2MASP2 | |
| SCHEMBL19292680 | 0.80 | HRH3 (0.54) | GRIK1ARG1HRH3F2MASP2 | |
| SCHEMBL1706921 | 0.80 | HRH3 (0.54) | GRIK1ARG1HRH3F2MASP2 | |
| SCHEMBL199034 | 0.80 | HRH3 (0.54) | GRIK1ARG1HRH3F2MASP2 | |
| SCHEMBL931868 | 0.80 | HRH3 (0.54) | GRIK1ARG1HRH3F2MASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170334823-A1 | METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS USING AMINE CATALYSTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-11-23 | — | — | US | disclosed |
| US-20170327448-A1 | METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS USING AMINE CATALYSTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170334823-A1 | METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS USING AMINE CATALYSTS | GK, ADH1A, ADH5 | GRIK1 658/4885ARG1 945/4885HRH3 254/4885 |
| US-20170327448-A1 | METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS USING AMINE CATALYSTS | GK, MSMO1, DGKG | GRIK1 247/4885ARG1 1580/4885HRH3 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.